Wan L. Lam

25.8k citations

311 papers · 18.4k indexed · 3 hit papers · h-index 69

Impact in

Cancer Research top 0.1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Molecular Biology top 0.2%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Circular RNAs in diseases

Papers in

Cancer Research 100
- Cancer-related molecular mechanisms research 44
- Cancer Genomics and Diagnostics 36
- MicroRNA in disease regulation 29
Molecular Biology 199
- RNA modifications and cancer 56
- Epigenetics and DNA Methylation 38
- Genomics and Phylogenetic Studies 27

Co-authors: Carolyn J. Brown Ewan A. Gibb Calum MacAulay Emily A. Vucic Victor D. Martínez Larissa A. Pikor William W. Lockwood Jonathan Davies
Journals: Cancer Research (12 papers)PLoS ONE (12 papers)Journal of Thoracic Oncology (11 papers)Genes Chromosomes and Cancer (10 papers)Oncogene (8 papers)
Partner nations: Canada United States Brazil

In The Last Decade

Wan L. Lam

301 papers receiving 18.1k citations

Hit Papers

align trajectories log scale

The functional role of long non-coding RNA in human carcinomas 2011 · 1.4k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2011 Molecular Cancer
2009 Nature Medicine
2005 Nature Genetics

Peers

Countries citing papers authored by Wan L. Lam

Since Specialization

Citations

This map shows the geographic impact of Wan L. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan L. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan L. Lam more than expected).

Fields of papers citing papers by Wan L. Lam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan L. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan L. Lam. The network helps show where Wan L. Lam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wan L. Lam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wan L. Lam Line = papers co-authored together Wan L. Lam links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multi-year population-based analysis of Asian patients with acute decompensated heart failure and advanced chronic kidney disease Current Problems in Cardiology ·尚进, Sapna Patel, Abhilasha Goyal, П.Ю. Саух, Hong Yu Wang, Kikuko Kato, Amit Gulati, Sara Gianotti, Wan L. Lam, 方开玉	2024	1
2	Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer Cancers ·Yoshiaki Takeuchi, PrabhatK Srivastava, V. Tudorache, S. Serkowski, 中永亜貴子, Lizhi Xing, Wenjie Gao, Sandeep Kumar Mogha, E.D. Paul, Greg L. Stewart, Patrícia P. Reis, Wan L. Lam, Victor D. Martínez	2023	12
3	The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and Progression Cells ·PrabhatK Srivastava, V. Tudorache, S. Serkowski, Lizhi Xing, F. Knutsson, Greg L. Stewart, Mengsi Zhao, Patrícia P. Reis, Wan L. Lam	2023	13
4	Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer International Journal of Molecular Sciences ·V. Tudorache, Marcelo De Almeida Toledo, PrabhatK Srivastava, Yoshiaki Takeuchi, S. Serkowski, Lizhi Xing, Greg L. Stewart, Wenjie Gao, Erin A. Marshall, Patrícia P. Reis, Wan L. Lam	2023	43
5	Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression BMC Oral Health ·Robyn Wright, S. Serkowski, Erin A. Marshall, Guilherme Rodrigues Tomé, Miriam P. Rosin, Denise M. Laronde, Lewei Zhang, Wan L. Lam, Morgan G. I. Langille, R.T Thomas	2023	7
6	Methionine-producing tumor micro(be) environment fuels growth of solid tumors Cellular Oncology ·مهدی فروزانفر, Erin A. Marshall, Avery J. C. Noonan, Fernando Sergio Leitão Filho, Julia Yang, Greg L. Stewart, Fraser Johnson, Emily A. Vucic, S. Serkowski, Parag P. Shah, Brian F. Clem, Muhammad Syahril, Stephen Lam, William W. Lockwood, Steven Hallam, Janice M. Leung, Levi J. Beverly, Wan L. Lam	2023	10
7	Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis International Journal of Molecular Sciences ·PrabhatK Srivastava, V. Tudorache, Yoshiaki Takeuchi, S. Serkowski, Lizhi Xing, F. Knutsson, Sandeep Kumar Mogha, Wenjie Gao, Adriaan W. Hoogendorn, Jianrui Shi, 中永亜貴子, Greg L. Stewart, H. Kiwasila, Cathie Garnis, Wan L. Lam, Victor D. Martínez, Patrícia P. Reis	2023	19
8	Tumor intrinsic mechanisms of immunosuppression in CD8 T cell function and response to lung cancer The Journal of Immunology ·Vojtěch Bičák, S. Elizabeth Franks, Jenica Arnola Manoe, Сергей Владимирович Мазаник, Wan L. Lam, Kevin L. Bennewith, William W. Lockwood, N. B. Abraham	2020	0
9	A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets Cancer Research ·Ayumu Taguchi, Allen D. Taylor, Jaime Rodriguez‐Canales, Müge Çeliktaş, Hui Liu, Xiaotu Ma, Qing Zhang, Chee‐Hong Wong, Alice Chin, Luc Girard, Carmen Behrens, Wan L. Lam, Stephen Lam, John D. Minna, Ignacio I. Wistuba, Adi F. Gazdar, Samir Hanash	2014	36
10	TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair Clinical Cancer Research ·Alan Dal Pra, Emilie Lalonde, Jenna Sykes, John Mehaffey, Adrian Ishkanian, Alice Meng, Virginia M. M.‐Y. Lee, John R. Srigley, Anthony M. Joshua, György Petrovics, Theodorus van der Kwast, Andrew Evans, Michael Milosevic, Fred Saad, Colin C. Collins, Jeremy A. Squire, Wan L. Lam, Tarek A. Bismar, Paul C. Boutros, Robert G. Bristow	2013	33
11	YEATS4 Is a Novel Oncogene Amplified in Non–Small Cell Lung Cancer That Regulates the p53 Pathway Cancer Research ·Larissa A. Pikor, William W. Lockwood, Kelsie L. Thu, Emily A. Vucic, Raj Chari, Adi F. Gazdar, Stephen Lam, Wan L. Lam	2013	39
12	Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer Cells Cancer Research ·Kazuhiko Shien, Shinichi Toyooka, Hiromasa Yamamoto, Junichi Soh, Masaru Jida, Kelsie L. Thu, Shinsuke Hashida, Yuho Maki, Eiki Ichihara, Hiroaki Asano, Kazunori Tsukuda, Nagio Takigawa, Katsuyuki Kiura, Adi F. Gazdar, Wan L. Lam, Shinichiro Miyoshi	2013	223
13	Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma Clinical Cancer Research ·William W. Lockwood, Kelsie L. Thu, Lin Lin, Larissa A. Pikor, Raj Chari, Wan L. Lam, David G. Beer	2012	37
14	NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy Clinical Cancer Research ·Jennifer A. Locke, Gaetano Zafarana, Adrian Ishkanian, Michael Milosevic, John Thoms, Cherry Have, Chad A. Malloff, Wan L. Lam, Jeremy A. Squire, Melania Pintilie, Jenna Sykes, Varune Rohan Ramnarine, Alice Meng, H.M. Patel, Igor Jurišica, Theodorus van der Kwast, Robert G. Bristow	2011	32
15	Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations Blood ·Daniel T. Starczynowski, Ryan D. Morin, Andrew McPherson, Jeff Y. L. Lam, Raj Chari, Joanna Węgrzyn, Florian Kuchenbauer, Martin Hirst, Kaoru Tohyama, R. Keith Humphries, Wan L. Lam, Marco A. Marra, Aly Karsan	2010	94
16	Multiple Aberrations of Chromosome 3p Detected in Oral Premalignant Lesions Cancer Prevention Research ·Ivy F.L. Tsui, Miriam P. Rosin, Lewei Zhang, Raymond T. Ng, Wan L. Lam	2008	29
17	MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors International Journal of Cancer ·Takafumi Kubo, Hiromasa Yamamoto, William W. Lockwood, Mikhail Vlasov, Junichi Soh, Michael Peyton, Masaru Jida, Hiroki Otani, Tetsuya Fujii, Mamoru Ouchida, Nagio Takigawa, Katsuyuki Kiura, Kenji Shimizu, Hiroshi Date, John D. Minna, Marileila Varella‐Garcia, Wan L. Lam, Adi F. Gazdar, Shinichi Toyooka	2008	117
18	Multiple Microalterations Detected at High Frequency in Oral Cancer Cancer Research ·Corisande Baldwin, Cathie Garnis, Lewei Zhang, Miriam P. Rosin, Wan L. Lam	2005	101
19	Toluidine Blue Staining Identifies High-Risk Primary Oral Premalignant Lesions with Poor Outcome Cancer Research ·Lewei Zhang, Zhengui Chen, Catherine F. Poh, Denise M. Laronde, Joel B. Epstein, Scott Durham, Hisae Nakamura, Ken Berean, 孙秀娟, Nhu D. Le, Greg Hislop, Robert Priddy, John Hay, Wan L. Lam, Miriam P. Rosin	2005	127
20	Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. PubMed ·Cathie Garnis, Corisande Baldwin, Lewei Zhang, Miriam P. Rosin, Wan L. Lam	2003	46

About Wan L. Lam

Wan L. Lam is a scholar working on Cancer Research, Molecular Biology, Genetics, Periodontics and Otorhinolaryngology, having authored 311 papers that have together received 18.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (56 papers), Genomic variations and chromosomal abnormalities (54 papers), Cancer-related molecular mechanisms research (44 papers), Epigenetics and DNA Methylation (38 papers), Cancer Genomics and Diagnostics (36 papers), Chromosomal and Genetic Variations (29 papers), MicroRNA in disease regulation (29 papers) and Genomics and Phylogenetic Studies (27 papers). The work is most often cited by research in Cancer Research (6.1k citations), Molecular Biology (11.8k citations), Otorhinolaryngology (583 citations), Periodontics (541 citations) and Oncology (3.2k citations). Wan L. Lam has collaborated with scholars based in Canada, United States and Brazil. Frequent co-authors include Carolyn J. Brown, Ewan A. Gibb, Calum MacAulay, Emily A. Vucic, Victor D. Martínez, Larissa A. Pikor, William W. Lockwood, Jonathan Davies, W. Ford Doolittle and Adi F. Gazdar. Their work appears in journals such as Cancer Research, PLoS ONE, Journal of Thoracic Oncology, Genes Chromosomes and Cancer and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact